Kinetics of PKCε activating and inhibiting llama single chain antibodies and their effect on PKCε translocation in HeLa cells.
Dysregulation of PKCε is involved in several serious diseases such as cancer, type II diabetes and Alzheimer's disease. Therefore, specific activators and inhibitors of PKCε hold promise as future therapeutics, in addition to being useful in research into PKCε regulated pathways. We have previo...
Main Authors: | Milla Summanen, Niko Granqvist, Raimo K Tuominen, Marjo Yliperttula, C Theo Verrips, Johannes Boonstra, Christophe Blanchetot, Elina Ekokoski |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22536418/?tool=EBI |
Similar Items
-
PKCε phosphorylation regulates the mitochondrial translocation of ATF2 in ischemia-induced neurodegeneration
by: Varun Kumar, et al.
Published: (2018-11-01) -
PKCε Activation Restores Loss of PKCε, Manganese Superoxide Dismutase, Vascular Endothelial Growth Factor, and Microvessels in Aged and Alzheimer’s Disease Hippocampus
by: Guetchyn Millien, et al.
Published: (2022-03-01) -
Exploring the prognostic significance of PKCε variants in cervical cancer
by: Sameen Zafar, et al.
Published: (2023-09-01) -
Ethanol-Induced Changes in PKCε: From Cell to Behavior
by: Rashidi M. Pakri Mohamed, et al.
Published: (2018-04-01) -
Opposed Actions of PKA Isozymes (RI and RII) and PKC Isoforms (cPKCβI and nPKCε) in Neuromuscular Developmental Synapse Elimination
by: Neus Garcia, et al.
Published: (2019-10-01)